Provided by Tiger Fintech (Singapore) Pte. Ltd.

Erasca, Inc.

1.55
-0.0550-3.44%
Volume:272.07K
Turnover:427.56K
Market Cap:438.27M
PE:-3.41
High:1.61
Open:1.58
Low:1.55
Close:1.60
52wk High:3.31
52wk Low:1.01
Shares:283.67M
Float Shares:167.46M
Volume Ratio:0.35
T/O Rate:0.16%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.4529
EPS(LYR):-0.6913
ROE:-31.16%
ROA:-17.92%
PB:1.18
PE(LYR):-2.23

Loading ...

Erasca Shares Fall After Downgrade From Morgan Stanley

MT Newswires Live
·
Aug 19

Erasca Cut to Equal-Weight From Overweight by Morgan Stanley

Dow Jones
·
Aug 18

Erasca, Inc. : Morgan Stanley Cuts to Equal-Weight From Overweight

THOMSON REUTERS
·
Aug 18

Erasca downgraded to Equal Weight from Overweight at Morgan Stanley

TIPRANKS
·
Aug 18

Cautious Outlook on Erasca Due to Strategic Shifts and Delayed Clinical Data

TIPRANKS
·
Aug 18

Erasca’s Strategic Advancements in RAS Programs Justify Buy Rating

TIPRANKS
·
Aug 14

Erasca Reports Progress and Financial Stability in Q2 2025

TIPRANKS
·
Aug 13

Erasca Q2 Loss Narrows, Cash Runway Good Until H2 2028

MT Newswires Live
·
Aug 13

Earnings Flash: (ERAS) Erasca Q2 Loss $0.12 Vs FactSet Est. $0.12 Loss

MT Newswires Live
·
Aug 13

Erasca Inc: Sale Agreement Prospectus Covering Offering of up $200 Mln Common Stock That May Be Issued Under Sale Agreement

THOMSON REUTERS
·
Aug 13

Erasca Inc reports results for the quarter ended June 30 - Earnings Summary

Reuters
·
Aug 13

Erasca Inc. Unveils Presentation on Their Mission to Erase Cancer and Innovative RAS/MAPK Pathway Strategies

Reuters
·
Aug 13

Erasca Q2 EPS $(0.12) Misses $(0.11) Estimate

Benzinga
·
Aug 13

BRIEF-Erasca Q2 Basic EPS USD -0.12

Reuters
·
Aug 13

Erasca Inc expected to post a loss of 11 cents a share - Earnings Preview

Reuters
·
Aug 09

Erasca (ERAS) Receives a Buy from Mizuho Securities

TIPRANKS
·
Jul 28

Mizuho Cuts Price Target on Erasca to $4 From $7, Keeps Outperform Rating

MT Newswires Live
·
Jul 28

Erasca Confirms Directors and Ratifies KPMG Appointment

TIPRANKS
·
Jun 27

Erasca Inc. Conducted Annual Stockholders Meeting

Reuters
·
Jun 27

Erasca Receives US FDA Approval of ERAS-4001 Investigational New Drug Application for Solid Tumors

MT Newswires Live
·
Jun 02